Aesthetic Rejuvenation: Promotes youthful skin regeneration for aesthetic enhancements
GLP-1 Connect was built to give people a place to have those conversations, learn from one another, and feel less alone on their journey." Members of GLP-1 Connect can: Connect with others using or considering GLP-1 therapies Share experiences related to diabetes, obesity, metabolic health, cardiovascular health, and chronic disease management Discuss treatment expectations, side effects, nutrition, exercise, and long-term wellness strategies Learn from peer experiences and community-driven conversations Access educational resources and support from individuals navigating similar health journeys Like all Inspire communities, GLP-1 Connect is free to join and is built around respectful, supportive conversations
Semaglutide, a glucagon-like peptide 1 receptor agonista class of medications used to treat obesity as well as type 2 diabetes
In SUSTAIN-6, in adults with type 2 diabetes at high cardiovascular risk, semaglutide reduced the same composite to 6.6% versus 8.9% (hazard ratio 0.74, about a 26% relative reduction)
Switching to tirzepatide before reaching at least 1.7 to 2.0 mg of semaglutide means you have not given semaglutide a full chance
For non-standard vial sizes or custom water volumes, use the Peptide Reconstitution Calculator to confirm your math before injecting